Nottinghamshire Area Prescribing Committee
Joint Formulary
Joint Formulary
Sub Chapters : 04 Central nervous system
- 5HT1 agonists
- 5HT3 antagonists
- Adjunctive therapy and symptomatic treatment
- Alcohol dependence
- Amantadine
- Analgesics
- Antihistamines
- Antimuscarinic drugs used in parkinsonism
- Anti-obesity drugs acting on the gastro-intestinal tract
- Antipsychotic depot injections
- Antipsychotic Drugs
- Benzodiazepines
- Benzodiazepines
- Benzodiazepines
- Benzodiazepines
- Buspirone
- Carbamazepine
- Carbamazepine and Oxcarbazepine
- Catachol-O-methyltransferase inhibitors
- Chloral and derivatives
- Cluster headache
- CNS stimulants and other drugs used for attention deficit hyperactivity disorder
- Compound analgesic preparations
- Domperidone and metoclopramide
- Dopamine receptor agonists
- Drugs for dementia
- Drugs used for mania and hypomania
- Drugs used in essential tremor, chorea, tics, and related disorders
- Drugs used in nausea and vertigo
- Drugs used in status epilepticus
- Febrile convulsions
- First-Generation Antipsychotic Drugs
- Gabapentin and pregabalin
- Hyoscine
- Hypnotics
- Levetiracetam
- Levodopa
- Lithium
- Monoamine-oxidase inhibitors
- Monoamine-oxidase-B inhibitors
- Neurokinin receptor antagonist
- Neuropathic pain
- Nicotine dependence
- Opioid analgesics
- Opioid substitution therapy
- Opioid-receptor antagonists
- Other antidepressant drugs
- Other Drugs
- Other drugs for Ménière's disease
- Phenobarbital and other barbiturates
- Phenothiazines and related drugs
- Postherpetic neuralgia
- Prophylaxis of migraine
- Related antidepressants
- Reversible MAOIs
- Second-Generation Antipsychotic Drugs
- Selective serotonin re-uptake inhibitors
- Sodium oxybate
- Torsion dystonias and other involuntary movements
- Tricyclic antidepressants
- Trigeminal neuralgia
- Valproate
- Valproic acid
- Zaleplon, Zolpidem and Zopiclone